Pathogenesis of Progression of Renal Insufficiency and Impact of Intervention
Relevance of Diet in the Progression of Renal Insufficiency, Saulo Klahr
Hypertension in Progressive Renal Disease, Johannes F. E. Mann, Karl F. Hilgers, Roland Veelken, and Isabelle Wolff
The Potential Role of Lipids in the Progression of Glomerular Diseases, Christoph J. Olbricht
Is Metabolic Acidosis a Risk Factor in the Progression of Renal Insufficiency?, F. John Gennari
Diabetic Nephropathy, Trond D. Jenssen
Myocardial Hypertrophy
Etiology and Pathophysiology of Left Ventricular Hypertrophy, Franz H. Messerli and Leszek Michalewicz
Uremic Cardiomyopathy, Eberhard Ritz, Ute Schwartz, Michael Rambausek, and Kerstin Amann
Microalbumin and Cardiovascular Risk in Hypertension, Bhuwnesh Agrawal and Friedrich C. Luft
Improvement of Coronary Microcirculation by ACE Inhibitors, S. Scheler, W. Motz, and B. E. Strauer
Dialysis Regimens and Myocardial Hypertrophy, W. H. M. van Kuijk, A. J. Luik, and K. M. L. Leunissen
Erythropoietin Therapy in Renal Failure
Evidence-Based Recommendations for the Clinical Use of rhEPO, N. Muirhead
Analysis of Safety Database for Long-Term Epoetin-b Treatment: A Meta-Analysis Covering 3697 Patients, J. Moecks, W. Franke, B Ehmer, O. Quarder, and P. Scigalla
Iron Therapy: Overview and Recommendations, Iain C. Macdougall
Continuous Administration of Intravenous Iron During Hemodialysis, C. Granolleras, A. Zein, R. Oules, B. Branger, J. Fourcade, and S. Shaldon
Erythropoietin and Kidney Transplantation, R. Vanholder and A. Van Loo
Effects of rhEPO on Regulation of Pulsatile Gonadotropin Secretion, Franz Schaefer, Birgit van Kaick, Guenter Stein, and Eberhard Ritz
Anemia Correction and Cardiac Function: Coronary Artery Disease and Left Ventricular Hypertrophy, V. Wizemann
